Precipio Enters Partnership with Clearbridge Health

Precipio (NASDAQ:PRPO) announced a multi-country agreement with Clearbridge Health where the company will provide tech for their laboratories in countries throughout Asia.
As quoted in the press release:

Precipio today announced a multi-country agreement with Clearbridge Health, to provide its ICE COLD-PCR (ICP) technology in CBH’s network of laboratories, serving patients in more than a dozen countries throughout Asia, including China, India, Taiwan, South Korea, Singapore, Malaysia, Indonesia, and Australia. Those laboratories will incorporate the Company’s ICP technology into their operations over the coming months, and are expected to begin offering liquid biopsy diagnostic services to local physicians soon thereafter. CBH will provide Precipio’s diagnostic services, as well as access to its world-class academic experts, to physicians and patients throughout the Clearbridge Health network. The agreement is expected to significantly increase Precipio’s footprint in the Asian market.
Clearbridge Health, Pte. is a Singapore-based medical group that aims to redefine healthcare in Asia by better enabling patient care through the deployment of precision and data-driven medical technologies. Its mission is to improve primary patient care by deploying advanced, best-in-class medical tests, making them available to clinicians throughout the region. A key focus of the agreement is the deployment of Precipio’s liquid biopsy diagnostic assays and panels for customized screening, profiling, and diagnoses.

Click here to read the full press release.

Source: www.accesswire.com